Moreover, the expression of LEF1/TCF transcription factors can beassociated with prognosis and treatment response in various cancer types, such ascolorectal and liver cancer (Lin et al.,2011; Li et al.,2014; Anwar et al., 2020), oralsquamous cell carcinomas (Su et al., 2014),acute lymphoblastic leukemia (Fischer et al.,2015), prostate cancer (Chen etal., 2018), and lung cancer (Zhu et al., 2015). This evidence concerns the gene LEF1 and prostate cancer.